163 related articles for article (PubMed ID: 34291681)
1. Antibiotic Use and Associated Risk Factors for Antibiotic Prescribing in COVID-19 Hospitalized Patients.
Martin AJ; Shulder S; Dobrzynski D; Quartuccio K; Pillinger KE
J Pharm Pract; 2023 Apr; 36(2):256-263. PubMed ID: 34291681
[TBL] [Abstract][Full Text] [Related]
2. Few bacterial co-infections but frequent empiric antibiotic use in the early phase of hospitalized patients with COVID-19: results from a multicentre retrospective cohort study in The Netherlands.
Karami Z; Knoop BT; Dofferhoff ASM; Blaauw MJT; Janssen NA; van Apeldoorn M; Kerckhoffs APM; van de Maat JS; Hoogerwerf JJ; Ten Oever J
Infect Dis (Lond); 2021 Feb; 53(2):102-110. PubMed ID: 33103530
[TBL] [Abstract][Full Text] [Related]
3. Bacterial infections and antibiotic utilization varies by coronavirus disease 19 (COVID-19) severity in hospitalized cancer patients: Analysis from the first phase of the pandemic.
Maki KR; Steiger SN; Su Y; Boumiza A; Tan CA; Kerpelev M; Seo SK; Cohen N
Infect Control Hosp Epidemiol; 2023 Mar; 44(3):413-419. PubMed ID: 35616016
[TBL] [Abstract][Full Text] [Related]
4. Reducing the use of empiric antibiotic therapy in COVID-19 on hospital admission.
Pettit NN; Nguyen CT; Lew AK; Bhagat PH; Nelson A; Olson G; Ridgway JP; Pho MT; Pagkas-Bather J
BMC Infect Dis; 2021 Jun; 21(1):516. PubMed ID: 34078301
[TBL] [Abstract][Full Text] [Related]
5. Bacterial co-infection and antibiotic stewardship in patients with COVID-19: a systematic review and meta-analysis.
Calderon M; Gysin G; Gujjar A; McMaster A; King L; Comandé D; Hunter E; Payne B
BMC Infect Dis; 2023 Jan; 23(1):14. PubMed ID: 36624396
[TBL] [Abstract][Full Text] [Related]
6. Developing a model for decision-making around antibiotic prescribing for patients with COVID-19 pneumonia in acute NHS hospitals during the first wave of the COVID-19 pandemic: qualitative results from the Procalcitonin Evaluation of Antibiotic use in COVID-19 Hospitalised patients (PEACH Study).
Henley J; Brookes-Howell L; Euden J; Pallmann P; Llewelyn M; Howard P; Powell N; Dark P; Szakmany T; Hellyer TP; Albur M; Hamilton R; Prestwich G; Ogden M; Maboshe W; Sandoe J; Thomas-Jones E; Carrol E; ;
BMJ Open; 2023 Dec; 13(12):e077117. PubMed ID: 38114276
[TBL] [Abstract][Full Text] [Related]
7. Antibiotic prescribing in patients with COVID-19: rapid review and meta-analysis.
Langford BJ; So M; Raybardhan S; Leung V; Soucy JR; Westwood D; Daneman N; MacFadden DR
Clin Microbiol Infect; 2021 Apr; 27(4):520-531. PubMed ID: 33418017
[TBL] [Abstract][Full Text] [Related]
8. A point prevalence survey to assess antibiotic prescribing in patients hospitalized with confirmed and suspected coronavirus disease 2019 (COVID-19).
Tan SH; Ng TM; Tay HL; Yap MY; Heng ST; Loo AYX; Teng CB; Lee TH
J Glob Antimicrob Resist; 2021 Mar; 24():45-47. PubMed ID: 33307276
[TBL] [Abstract][Full Text] [Related]
9. Characteristics of procalcitonin in hospitalized COVID-19 patients and clinical outcomes of antibiotic use stratified by procalcitonin levels.
So W; Simon MS; Choi JJ; Wang TZ; Williams SC; Chua J; Kubin CJ
Intern Emerg Med; 2022 Aug; 17(5):1405-1412. PubMed ID: 35277828
[TBL] [Abstract][Full Text] [Related]
10. Antibiotic use during the first 6 months of COVID-19 pandemic in Iran: A large-scale multi-centre study.
Salehi M; Khalili H; Seifi A; Davoudi H; Darazam IA; Jahangard-Rafsanjani Z; Mohammadnejad E; Heydari B; Siahkaly SJM; Tabarsi P; Kalantari S; Menshadi SAD; Babamahmoodi F; Khorvash F; Davarpanah MA; Soltani R; Yaghoobi MH; Anari SAM; Khodadadi J; Aliramezani A; Hantooshzadeh S; Naderi HR; Hajiabdolbaghi M; Elyasi S; Firouzabadi D; Kasgari HA; Roshanzamiri S; Ebrahimpour S
J Clin Pharm Ther; 2022 Dec; 47(12):2140-2151. PubMed ID: 36054303
[TBL] [Abstract][Full Text] [Related]
11. Antimicrobial use in patients with confirmed COVID-19 infection in the Philippines: a cross-sectional study.
Dominguez RJ; Domingo-Cereno NA; Josue-Dominguez RT
Western Pac Surveill Response J; 2023; 14(2):1-8. PubMed ID: 37475781
[TBL] [Abstract][Full Text] [Related]
12. Antimicrobial stewardship in the UK during the COVID-19 pandemic: a population-based cohort study and interrupted time-series analysis.
Rezel-Potts E; L'Esperance V; Gulliford MC
Br J Gen Pract; 2021 May; 71(706):e331-e338. PubMed ID: 33690150
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of bacterial coinfection and patterns of antibiotics prescribing in patients with COVID-19: A systematic review and meta-analysis.
Alshaikh FS; Godman B; Sindi ON; Seaton RA; Kurdi A
PLoS One; 2022; 17(8):e0272375. PubMed ID: 35913964
[TBL] [Abstract][Full Text] [Related]
14. Antibiotic stewardship: Early discontinuation of antibiotics based on procalcitonin level in COVID-19 pneumonia.
Roy A; Powers HR; Craver EC; Nazareno MD; Yarrarapu SNS; Sanghavi DK
J Clin Pharm Ther; 2022 Feb; 47(2):243-247. PubMed ID: 34766357
[TBL] [Abstract][Full Text] [Related]
15. Elucidating the role of procalcitonin as a biomarker in hospitalized COVID-19 patients.
Cowman K; Rossi J; Gendlina I; Guo Y; Liu S; Szymczak W; Forest SK; Wolgast L; Orner E; Bao H; Cervera-Hernandez ME; Ceniceros A; Thota R; Pirofski LA; Nori P
Diagn Microbiol Infect Dis; 2022 Aug; 103(4):115721. PubMed ID: 35635888
[TBL] [Abstract][Full Text] [Related]
16. Identifying targets for antibiotic stewardship interventions through analysis of the antibiotic prescribing process in hospitals - a multicentre observational cohort study.
Wathne JS; Skodvin B; Charani E; Harthug S; Blix HS; Nilsen RM; Kleppe LKS; Vukovic M; Smith I
Antimicrob Resist Infect Control; 2020 Jul; 9(1):114. PubMed ID: 32693826
[TBL] [Abstract][Full Text] [Related]
17. Survey of antibiotic and antifungal prescribing in patients with suspected and confirmed COVID-19 in Scottish hospitals.
Seaton RA; Gibbons CL; Cooper L; Malcolm W; McKinney R; Dundas S; Griffith D; Jeffreys D; Hamilton K; Choo-Kang B; Brittain S; Guthrie D; Sneddon J
J Infect; 2020 Dec; 81(6):952-960. PubMed ID: 32987097
[TBL] [Abstract][Full Text] [Related]
18. Early Empiric Antibiotic Use in Patients Hospitalized With COVID-19: A Retrospective Cohort Study.
Widere JC; Davis CL; Loomba JJ; Bell TD; Enfield KB; Barros AJ;
Crit Care Med; 2023 Sep; 51(9):1168-1176. PubMed ID: 37125800
[TBL] [Abstract][Full Text] [Related]
19. Hospital antibiotic consumption-an interrupted time series analysis of the early and late phases of the COVID-19 pandemic in Poland, a retrospective study.
Siewierska M; Gajda M; Opalska A; Brudło M; Krzyściak P; Gryglewska B; Różańska A; Wójkowska-Mach J
Pharmacol Rep; 2023 Jun; 75(3):715-725. PubMed ID: 37017868
[TBL] [Abstract][Full Text] [Related]
20. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
